Institut für Lebensmittelchemie und Toxikologie, Universität Karlsruhe, Postfach D-76128 Karlsruhe, Germany
1 To whom correspondence should be addressed Email: andrea.hartwig{at}chemie.uni-karlsruhe.de
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Abbreviations: AP sites, apurinic/apyrimidinic sites; DMA(III), dimethylarsinous acid; DMA(V), dimethylarsinic acid; MMA(III), monomethylarsonous acid; MMA(V), monomethylarsonic acid.
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In humans, like in many mammalian species, inorganic arsenic is almost quantitatively reduced from pentavalent to trivalent arsenic in plasma and subsequently methylated to the trivalent and pentavalent methylated metabolites in the liver (summarized in ref. 13). Dimethylarsinic acid [DMA(V)] is the main urinary metabolite, with normal urinary excretion profiles of 1020% inorganic arsenic, 1020% monomethylarsonic acid [MMA(V)] and 6080% DMA(V) (14). Generally, the in vivo biomethylation and excretion of inorganic arsenic as MMA(V) and DMA(V) has long been thought to be one major detoxification process as the pentavalent methylated metabolites are less reactive towards cellular macromolecules and are eliminated more rapidly (14,15). In support of this assumption, Moore et al. (16) demonstrated that MMA(V) and DMA(V) are less cytotoxic, mutagenic and clastogenic as compared with arsenite and arsenate in the L5178Y/TK+/- mouse lymphoma assay. However, for DMA(V) there is some evidence for being a complete carcinogen in rats (reviewed in ref. 17). Furthermore, it has been shown to induce DNA damage via formation of dimethylarsenic peroxyl radical, superoxide anion or hydroxyl radicals in laboratory animals (1821) and cultured cells (2225) but effects were restricted mainly to high, in the case of cellular systems, millimolar concentrations. Only one study showed increased DNA migration in single cell gel electrophoresis (comet assay) in lymphocytes treated with micromolar concentrations of MMA(V) and DMA(V), indicating DNA strand break formation (26).
However, in addition to the pentavalent metabolites, both monomethylarsonous [MMA(III)] and dimethylarsinous acid [DMA(III)] have been identified as intermediates in the metabolic pathway and have been detected in cultured human cells treated with inorganic arsenic (summarized in ref. 27). Also, Mandal et al. (28) reported the presence of MMA(III) (25% of urinary arsenic) and DMA(III) (421% of urinary arsenic) in the urine of people chronically exposed to inorganic arsenic via drinking water in West Bengal, India. Trivalent methylated metabolites are more cytotoxic in cultured mammalian cells (29,30) and more potent inhibitors of the activities of some important enzymes as compared with arsenite (summarized in ref. 27). Nevertheless, only a few data are available with respect to the genotoxicity of the trivalent methylated metabolites. Applying the comet assay, Mass et al. (31) demonstrated that DMA(III) and MMA(III) were more potent in generating DNA strand breaks in human lymphocytes as compared with arsenite. Furthermore, there is evidence that DMA(III) (31,32) and at very high concentrations (30 mM) MMA(III) (31) are able to nick isolated DNA without enzymatic or chemical activation.
The aim of the present study was to compare the induction of DNA strand breaks and oxidative DNA base modifications by arsenite and its trivalent and pentavalent metabolites MMA(III), DMA(III), MMA(V) and DMA(V) in cultured human cells at low, non-cytotoxic concentrations after short- and long-term incubations to elucidate potential contributions of methylated metabolites in arsenic-induced genotoxicity. Furthermore, comparative studies with isolated PM2 DNA were performed to clarify the role of cellular reactions involved in DNA damage induction.
![]() |
Materials and methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Materials
Ham's F12 nutrient mixture, fetal bovine serum, trypsin, penicillinstreptomycin solutions, trizma base and ficoll 400 are products of Sigma (Deisenhofen, Germany). The culture dishes were supplied by Biochrom (Berlin, Germany). Triton X-100 was bought from Pierce (Oud-Beijerland, The Netherlands), hydroxyapatite (high resolution) from Calbiochem (Bad Soden, Germany). AsNaO2 (99% purity), ethidium bromide, xylene cyanol FF were obtained from Fluka Chemie (Buchs, Germany) and DMA(V) (
98.8% purity) from Riedel-de Haën (Seelze, Germany). MMA(V) (>96% purity) was purchased from Greyhound Chromatography and Allied Chemicals (Birkenhead, Merseyside, UK). Methyloxoarsine (CH3AsIIIO), diiodomethylarsine (CH3AsI2) and iododimethylarsine [(CH3)2AsIIII] were kindly provided by W.R.Cullen (University of British Columbia, Vancouver, Canada). All three compounds were of
99% purity. Sodium dodecylsulfate (SDS) and bromphenol blue sodium salt as well as all other chemicals were of p.a. grade and from Merck (Darmstadt, Germany). The Fpg protein was a kind gift of Serge Boiteux (Fontenay aux Roses, France). The concentration applied in our system (1 µg/ml) is based on the determination of saturated lesion recognition.
Cell culture and incubation
HeLa S3 cells were grown in tissue culture dishes as monolayers in Ham's F12 nutrient mixture containing 10% fetal bovine serum, 100 U penicillin/ml and 100 µg streptomycin/ml. The cells were incubated at 37°C with 5% CO2 in air and 100% humidity. Logarithmically growing cells were treated with the diverse arsenic compounds as described for the respective experiments. Arsenical stock solutions were prepared in sterile distilled water. To prevent oxidation of trivalent arsenicals, stock solutions were prepared shortly before each experiment.
Colony forming ability
Logarithmically growing cells were treated as described for the respective experiments, trypsinized, counted and 300 cells/dish were seeded. After 7 days of incubation, colonies were fixed with ethanol, stained with Giemsa (25% in ethanol), counted and calculated as percent of control. Untreated controls exhibited colony forming abilities of 80%.
Induction of oxidative DNA damage in cultured cells
DNA strand breaks and Fpg-sensitive sites were determined by the alkaline unwinding technique in combination with the bacterial formamidopyrimidineDNA glycosylase (Fpg) as described elsewhere (33). Briefly, 1 x 105 cells were seeded and allowed to attach for at least 24 h before treatment with the test chemicals. At the end of treatment, the culture medium was removed, cells were washed with cold Ham's F12 and a lysis buffer was added containing 0.006 M Na2HPO4, 0.001 M KH2PO4, 0.137 M NaCl, 0.003 M KCl and 0.1% Triton X-100. After 5 min on ice, the solution was removed by aspiration and the cells were treated with a high salt solution containing 2 M NaCl, 0.01 M EDTA and 0.002 M Tris (pH 8.0) for 2 min on ice, whereafter the cells were left on ice for an additional 8 min. The nucleoids were then incubated with Fpg (1 µg/ml) in enzyme buffer (0.05 M sodium phosphate, 0.01 M EDTA, 0.1 M NaCl, pH 7.5) for 30 min at 37°C. For the detection of DNA strand breaks, Fpg was omitted. At the end of incubation, an alkaline solution was added yielding a final concentration of 0.07 N NaOH, 0.013 M EDTA and 0.37 M NaCl, pH 12.3, and the DNA was allowed to unwind for 30 min in the dark. The further steps of unwinding, neutralization and separation of single- and double-stranded DNA were performed as described previously (33). Briefly, the solution was neutralized with HCl, sonicated and SDS was added to a final concentration of 0.05%. Separation of single- and double-stranded DNA was performed on 0.5 ml hydroxyapatite columns at 60°C, where single- and double-stranded DNA were eluted with 1.5 ml of 0.15 M and 0.35 M potassium phosphate buffer, respectively. The DNA content of both fractions was determined by adding Hoechst 33258 (final concentration of 7.5 x 10-7 M) to 1 ml of each sample and measuring the fluorescence with a spectrophotofluorometer (SPECTRA Fluor, Tecan) at an excitation wavelength of 360 nm and an emission wavelength of 455 nm. The fraction of double-stranded DNA and lesion frequencies were calculated as described before (33).
Induction of oxidative DNA damage in isolated PM2 DNA
PM2 is a bacteriophage with a circular DNA of 10 kb, which was purified as described elsewhere (34). PM2 DNA prepared by this procedure retained 90% supercoiled molecules. Linear DNA fragments were not detected.
To investigate the induction of DNA strand breaks and Fpg-sensitive sites in PM2 DNA by the arsenicals, PM2 DNA (30 µg/ml) was dissolved in buffer (40 mM sodium phosphate, 100 mM NaCl, pH 7.4) and incubated with the respective arsenic compound for 60 min at 37°C. Afterwards PM2 DNA was precipitated with ethanol/125 mM sodium acetate for 30 min and centrifuged for 5 min at 7000 g. After washing the DNA pellet twice with ethanol/125 mM sodium acetate, removal of the supernatant and resuspension of the DNA pellet in buffer, PM2 DNA (10 µl; 200 ng/sample) was incubated with Fpg (final concentration 1 µg/ml; 30 µl/sample) for 30 min at 37°C. For the detection of DNA strand breaks only, Fpg was omitted in the last step. The reaction was terminated by adding 7 µl stop solution (0.25% bromphenol blue, 0.25% xylene cyanol, 15% Ficoll 400). Supercoiled and open circular forms of PM2 molecules were separated by electrophoresis in a 1% agarose gel in buffer (890 mM Trizma base, 890 mM boric acid, 10 mM EDTA) for 2.5 h at 90 V. After staining with ethidium bromide, the density of the bands was measured using a Herolab gel detection system (EASY win 32). The number of DNA strand breaks and Fpg-sensitive sites were calculated as described before (34,35).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cytotoxicity
The cytotoxicity was determined by investigating the effect of the respective arsenic compound on colony forming ability after 18 h incubation. The trivalent methylated metabolites MMA(III) and DMA(III) exerted higher cytotoxicity as compared with arsenite and especially to the pentavalent methylated metabolites MMA(V) and DMA(V) (Figure 1).
|
Arsenite
In a first approach, HeLa S3 cells were incubated for 0.5, 1 or 3 h with 0.0011.0 µM arsenite. For all incubation times and concentrations applied we observed only low levels of DNA strand breaks up to 0.2 lesions/106 bp (data not shown). Next, the generation of Fpg-sensitive sites was investigated. The steady-state level of 0.2 Fpg-sensitive sites/106 bp was significantly increased at very low concentrations of arsenite in a time- and dose-dependent manner (Figure 2A). Whereas only a few additional Fpg-sensitive sites were detectable at 0.001 µM arsenite after 1 and 3 h incubation, up to 1.34 Fpg-sensitive sites/106 bp were induced by 0.01 µM. To ensure that the induction of Fpg-sensitive sites by arsenite is not restricted to HeLa S3 cells, a second cell line, human lung adenocarcinoma cells (A549), was applied. Again, non-cytotoxic concentrations of 0.110 µM arsenite induced only a few DNA strand breaks but up to 0.8 Fpg-sensitive sites/106 bp after 3 h incubation (data not shown).
|
Trivalent methylated metabolites
After 3 h incubation both trivalent methylated metabolites MMA(III) and DMA(III) induced only a few DNA strand breaks, but Fpg-sensitive sites at very low, non-cytotoxic concentrations in a dose-dependent manner starting at 0.1 µM (Figures 3A and 4A). In contrast to arsenite, considerable amounts of DNA lesions were still detectable after 18 h incubation. MMA(III) generated DNA strand breaks and to a lesser extent Fpg-sensitive sites in a concentration-dependent manner starting at 0.1 µM (Figure 3B). Compared with 3 h incubation the frequency of Fpg-sensitive sites was about two to three times lower after 18 h incubation, except for the highest concentration, 5 µM MMA(III), which induced a comparable amount of 0.3 Fpg-sensitive sites/106 bp at both time points. However, the total lesion frequency was about the same (0.1 and 0.5 µM) or even higher (1.0 and 5 µM) after 18 h incubation.
|
|
Pentavalent methylated metabolites
Comparable with arsenite and the trivalent methylated metabolites, DMA(V) and MMA(V) induced only low levels of DNA strand breaks in HeLa S3 cells after 3 h incubation (Figures 5A and 6A), but pronounced levels of Fpg-sensitive sites in a time-dependent manner, reaching values of 0.8 and 0.9 Fpg-sensitive sites/106 bp for 250 µM MMA(V) or DMA(V) after 3 h, respectively.
|
|
Induction of DNA strand breaks and Fpg-sensitive sites in isolated PM2 DNA
To investigate whether arsenite and/or the trivalent and pentavalent metabolites damage isolated DNA directly, we assessed the effect of the arsenicals on the induction of DNA strand breaks and Fpg-sensitive sites after 1 h incubation of isolated PM2 DNA at 37°C. Neither arsenite, the pentavalent metabolites MMA(V) and DMA(V), nor MMA(III) generated DNA strand breaks or Fpg-sensitive sites in isolated PM2 DNA up to 10 mM (data not shown). However, DMA(III) induced significant amounts of DNA strand breaks in a concentration-dependent manner starting at 10 µM in the absence of Fpg-sensitive sites (Figure 7).
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Concerning the cytotoxicity, the trivalent methylated metabolites were more cytotoxic as compared with arsenite, with MMA(III) being the most cytotoxic compound in HeLa S3 cells. Whereas MMA(III) and DMA(III) showed cytotoxic effects in the low micromolar concentration range, both pentavalent methylated metabolites were only slightly cytotoxic even at concentrations up to 500 µM. These findings are in agreement with several new studies investigating the cytotoxicity of arsenic compounds in primary rat and human cells (30) and human hepatocytes (29). One reason for these differences may be the lower cellular uptake/retention of the pentavalent metabolites as compared with the trivalent compounds (39). Altogether, for cytotoxicity of the arsenicals the oxidation state appears to have a higher impact than the degree of methylation.
With respect to DNA damage our data support the hypothesis raised by Mass et al. (31) that the trivalent methylated arsenic species are genotoxic and may contribute to arsenite-induced genotoxicity/carcinogenicity. Nevertheless, our data provide additional information in some important aspects showing significant amounts of DNA damage not only by MMA(III) and DMA(III), but also by very low non-cytotoxic concentrations of arsenite, DMA(V) and MMA(V). The differences to former investigations are mainly due to the inclusion of the Fpg protein in the present study, which enables the quantification of oxidative DNA base modifications including 8-oxoguanine in addition to DNA strand breaks.
Short-term incubations (0.53 h) with arsenite induced only a few DNA strand breaks; however, high amounts of Fpg-sensitive sites were generated at concentrations as low as 0.011 µM arsenite in two different human cell lines, HeLa S3 and A549. In principle, our data are in agreement with recent studies conducted with the comet assay where Fpg increased the level of DNA strand breaks after short-term incubation (24 h) with arsenite in mammalian cells. Thus, Wang et al. (11) demonstrated that 4 h treatment of CHO-K1 cells with up to 2 µM arsenite did not induce DNA strand breaks; however, when Fpg or Proteinase K ingestion was incorporated into the comet assay, significant strand breakage was detected using arsenite concentrations as low as 0.25 µM. Similar effects were observed by Lynn et al. (6), Liu et al. (7) and Li et al. (9). Nevertheless, in the present study the effects were observed at even lower, nanomolar concentrations. Altogether, it appears that DNA strand break assays in the absence of Fpg or proteinase K underestimate the genotoxic potential of arsenite.
Like arsenite, the trivalent and pentavalent methylated metabolites induced only few DNA strand breaks but pronounced levels of oxidative DNA base modifications after short-term incubation (0.53 h) at somewhat higher but still non-cytotoxic concentrations in HeLa S3 cells. In the case of DMA(V) these results seem to contradict most previous reports where DNA damage including DNA strand breaks, DNAprotein crosslinks and AP sites in human alveolar epithelial type II (L-132) cells were restricted to high, in the case of cellular systems, millimolar concentrations (2325); nevertheless as discussed for arsenite, Fpg-sensitive sites may be a more sensitive indicator of oxidative DNA damage after treatment with arsenicals.
However, the underlying mechanisms for the induction of oxidative DNA damage by the different arsenic compounds investigated still remain unclear. Recent studies have provided evidence that arsenite can induce DNA damage by promoting the formation of reactive oxygen species, particularly superoxide radical anions and hydrogen peroxide (6,10,11). Furthermore, reactive oxygen species scavengers such as superoxide dismutase, catalase, glutathione peroxidase and DMSO counteracted the formation of deletion mutations in human chromosome 11 in a humanhamster hybrid cell line (40), of micronuclei and of sister chromatid exchanges (4143).
Concerning the methylated metabolites, our data as well as some reports in the literature suggest that no common mechanism for DNA damage induction applies for all compounds investigated. Thus, in the present study only DMA(III) at concentrations as low as 10 µM induced DNA strand breaks but no Fpg-sensitive sites in isolated PM2 DNA whereas in cells mainly Fpg-sensitive sites were detected. This indicates that on cellular conditions lesions are generated not by DMA(III) itself but rather by reactive species formed inside the cell. In contrast to DMA(III), arsenite, MMA(III), MMA(V) and DMA(V) showed no effects on isolated DNA up to 10 mM, indicating again the importance of cellular components for lesion induction. With respect to DMA(V), electron spin resonance studies provided evidence that besides the superoxide radical anion a dimethylarsenic peroxyl radical was formed by the reaction of molecular oxygen with dimethylarsine, a product in the further metabolic processing of DMA(V), which may form DNA adducts and subsequently AP sites and DNA protein crosslinks (22,24). Thus, at least some Fpg-sensitive sites in our study may be AP sites. As another potential mechanism for the generation of ROS and oxidative DNA damage, Ahmad et al. (32,44) reported the release of iron from horse spleen and human liver ferritin by arsenite, arsenate and the methylated metabolites with strongest effects exerted by DMA(III). Furthermore, the addition of human liver ferritin increased the DNA damage on isolated pBR322 DNA by DMA(III). Nevertheless, whether this mechanism is relevant in intact cells has to be further elucidated. In cellular systems, in addition to a direct increase in ROS, arsenite and especially some of the methylated metabolites may induce oxidative DNA damage indirectly by inhibition of important detoxifying enzymes. Thus, both trivalent methylated metabolites MMA(III) and DMA(III) are more potent inhibitors of isolated glutathione reductase (summarized in ref. 27) as compared with arsenite, which may be due to the interaction of trivalent arsenic with critical thiol groups and may alter the cellular redox status.
One very interesting outcome of this study concerns the persistence of oxidative DNA damage, which was clearly different for arsenite and its trivalent and pentavalent methylated metabolites. Thus, far less lesions were detected after 18 h incubation with arsenite as compared with 3 h incubation, whereas both trivalent and pentavalent methylated metabolites increased the extent of oxidative DNA damage also after 18 h incubation at non-cytotoxic concentrations in HeLa S3 cells. As the frequency of Fpg-sensitive sites resembles a steady-state between damage induction and repair, removal of oxidative DNA base modifications taking place in the presence of low arsenite concentrations might be a plausible explanation, whereas the methylated metabolites may interfere with the repair of the induced lesions. Thus, in the case of MMA(III) and DMA(V) far more DNA strand breaks were observed after 18 h incubation as compared with short-term treatment, which may be indicative of ongoing or inhibited repair processes. Even though this issue has not been investigated systematically up to now; preliminary and yet unpublished data from our laboratory revealed an inhibition of Fpg by MMA(III) and DMA(III) whereas neither arsenite nor the pentavalent methylated metabolites showed any effect (T.Schwerdtle, I.Walter and A.Hartwig, unpublished observations). Nevertheless, other explanations cannot be excluded. Thus, uptake of the pentavalent metabolites into cells is slower as compared with arsenite and thus DNA damage induction may be shifted towards later time points; nevertheless, uptake of MMA(III) is more efficient and about as fast as arsenite (30).
Taken together, our results demonstrate the generation of oxidative DNA damage by arsenite and all methylated metabolites investigated, even though the underlying mechanisms of DNA damage induction appear to be quite different. Very low concentrations of arsenite lead to DNA damage under conditions where due to the low methylation capacity of HeLa S3 cells (45,46) no relevant formation of methylated metabolites is expected. Furthermore, even if the methylation capacity would be sufficient to metabolize these very low concentrations of arsenite, even higher concentrations of the metabolites would be required to induce comparable amounts of DNA damage. On the other hand, the trivalent metabolites were more potent in generating persistent oxidative DNA damage detected after 18 h incubation as compared with arsenite at still submicromolar concentrations as well. Concerning the pentavalent metabolites, DNA damage was observed at higher but still non-cytotoxic concentrations. Nevertheless, it has to be taken into account that uptake into cells is probably very low, whereas in humans the metabolites are generated inside the cell and may generate DNA damage at much lower concentrations. Thus, further studies are needed to assess the effective intracellular concentrations and speciation after incubation with the respective arsenic compounds in cultured cells.
In summary, the data suggest that biomethylation of arsenite is no prerequisite for the arsenite-induced genotoxicity but may additionally contribute to genetic alterations. The biologically probably most crucial lesion recognized by the Fpg protein is 8-oxoguanine. If not repaired, this lesion has mutagenic properties causing GC to TA transversions (47). The potential relevance of the data presented in this study becomes obvious when comparing the applied concentrations of arsenite with blood concentrations of arsenic on environmental exposure conditions. Total arsenic concentrations in whole blood of people with low known exposure to arsenic cover a range of 427 nM, whereas exposure to arsenic in drinking water containing 100, 200 or 400 µg/l arsenic corresponded to mean whole blood concentrations of about 55, 133 or 173 nM, respectively (summarized in refs 1,2). Since in our study, concentrations as low as 10 nM arsenite or 100 nM of the trivalent methylated metabolites induced significant amounts of DNA damage, the findings will help to understand the carcinogenicity of arsenic compounds at extremely low exposure conditions.
During revision of this paper, Wang et al. (48) reported on independently derived data on DNA damage by arsenite and some methylated metabolites determined by comet assay. In agreement with our results, they observed enzyme-sensitive sites generated by comparatively low concentrations of arsenite, DMA(V), MMA(V) and MMA(III) after short-term incubation of HL 60 cells.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|